Researchers from The University of Texas at El Paso’s School of Pharmacy will explore the viability of a new treatment for vascular dementia, thanks to a $2.2 million… read more.
New research from the University of Cambridge and the University of Melbourne, published in Science Advances, shows neurotypical workers and students taking cognitive enhancers, or ‘smart’ drugs, may actually be… read more.
Young men with cannabis (marijuana) use disorder have an increased risk of developing schizophrenia, according to a study led by researchers at the Mental Health Services in the… read more.
People with severe mental illness are less likely to attend cancer screening compared to those who do not have such conditions, according to new research from the University… read more.
Researchers at UNSW Sydney and Neuroscience Research Australia (NeuRA) have developed and evaluated a tool for assessing dementia risk, with promising initial results. Currently, over 55 million people are living with dementia… read more.
A new study from the Karolinska Institutet in Sweden suggests that electroconvulsive therapy (ECT), lithium, and clozapine may be associated with reduced suicide rates in adolescent males with… read more.
Among patients over 60 with treatment-resistant depression, adding the antipsychotic drug aripiprazole (Abilify) to their treatment appears to be a more effective strategy than switching antidepressants. Researchers reported… read more.
People with hearing loss who do not use hearing aids appear to be at a higher risk of developing dementia than people with hearing loss who use hearing… read more.
Taking vitamin D supplements may help ward off dementia, according to a new, large-scale study by scientists in the UK and Canada, using data from US patients. Based… read more.
Researchers at the University of Calgary in Canada and the University of Exeter in the United Kingdom explored the relationship between vitamin D supplementation and dementia in more… read more.
Even though pediatric emergency department visits decreased greatly overall during the COVID-19 pandemic, a newly published study led out of the University of Calgary shows there was also… read more.
New research at the University of Chicago Medicine has found that a drug commonly used to treat symptoms of Alzheimer’s disease effectively reduced symptoms of adults who experience… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
